Angiotensin II antagonists in heart failure – clinical trials review

Marcin Grabowski; Krzysztof J. Filipiak; Grzegorz Opolski

ISSN: 1505-8409

Przewodnik Lekarza/Guide for GPs

Current issue Archive About the journal Supplements Contact Instructions for authors

5/2005
vol. 8

Send email

Copy url:

abstract:

Angiotensin II antagonists in heart failure – clinical trials review

Marcin Grabowski

,

Krzysztof J. Filipiak

,

Grzegorz Opolski

Przew Lek 2005; 5: 78-82

Online publish date: 2005/07/15

View full text Get citation

Angiotensin II receptor antagonists act by a different mechanism than the angiotensin converting enzyme inhibitors, although both reduce the stimulation of angiotensin II receptors. Trials of these agents have been conducted to determine whether they have a comparable benefit in patients with heart failure. The clinical data that have addressed the use of angiotensin II receptor antagonists in patients with heart failure will be reviewed here.

keywords:

Angiotensin II antagonists in heart failure – clinical trials review

Marcin Grabowski , Krzysztof J. Filipiak , Grzegorz Opolski

angiotensin II antagonist, heart failure, clinical trials

Marcin Grabowski

,

Krzysztof J. Filipiak

,

Grzegorz Opolski